ACTRN12610000546055
Recruiting
Phase 2
A pilot study comparing the efficacy and tolerability of artesunate alone and artesunate plus azithromycin for the treatment of Plasmodium falciparum malaria in central Vietnam
Australian Army Malaria Institute0 sites60 target enrollmentJuly 7, 2010
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Malaria infection
- Sponsor
- Australian Army Malaria Institute
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(i) Patients with falciparum malaria with parasitaemia between 100 and 200,000 parasites/uL of blood
- •(ii) Is willing to give small amounts of blood via finger prick and phlebotomy
- •(iii) Written informed consent and agreed to treatment follow\-up for a total of 28 days for artesunate alone and 42 days for artesunate plus azithromycin.
Exclusion Criteria
- •(i) Severe/cerebral malaria or history of another serious medical disease
- •(ii) Prior treatment with an artemisinin drug within the previous 7 days
- •(iii) Pregnancy and lactating
- •(iv) Inability to communicate well with the investigator (poor mental development or evidence of psychiatric disorder)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A Clinical Trial to Compare Efficacy and Tolerability of Atorvastatin in Addition to Endocrine Based Treatment with Focus on Mechanisms of Resistance to Endocrine Based Treatment (fulvestrant/aromatase inhibitors alone or in combination with a cdk4/6 inhibitor) in Patients With Advanced Breast CancerEstrogen receptor positive metastatic or locally advanced inoperable breast cancer.MedDRA version: 20.0Level: LLTClassification code 10006192Term: Breast cancer NOSSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Cancer [C04]EUCTR2016-000494-20-SESkåne University Hospital, Department of Oncology126
Not yet recruiting
Not Applicable
Investigating the proposed effect of low-level laser therapy in providing pain relief in human teethDental analgesiaDental anaesthesiaAnaesthesiology - Pain managementOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12623001143617Griffith University30
Active, not recruiting
Not Applicable
Study to compare two gels that are used to treat acne vulgaris. It will be compared the tolerability and effectivity following application of two combination topical acne products clindamycin 1% and 0.025% tretinoin gel (Acnatac® Gel), adapalen 0,1% and benzoyl peroxide 2,5% gel (Epiduo® Gel).acne vulgarisTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2015-002699-26-DEGWT-TUD GmbH
Completed
Phase 4
A study comparing the efficacy and tolerability of Co-amoxiclav,Cefpodoxime and Levofloxacin in tonsillitisHealth Condition 1: null- Acute, uncomplicated bacterial tonsillitisCTRI/2018/05/013756Kempegowda Institute of Medical Sciences90
Completed
Phase 2
Study of a combination of fenugreek/phaseolamin as a new weight loss agentObesityDiet and Nutrition - ObesityACTRN12607000130460Southern European Health Marketing Ltd39